Literature DB >> 16873445

FK506-binding protein 52 is essential to uterine reproductive physiology controlled by the progesterone receptor A isoform.

Zuocheng Yang1, Irene M Wolf, Hanying Chen, Sumudra Periyasamy, Zhuang Chen, Weidong Yong, Shu Shi, Weihong Zhao, Jianming Xu, Arun Srivastava, Edwin R Sánchez, Weinian Shou.   

Abstract

FK506-binding protein 52 (FKBP52) is a tetratricopeptide repeat protein that associates with steroid receptors in complexes containing heat shock protein 90. To investigate the role of FKBP52 in steroid-regulated physiology, we generated FKBP52-deficient mice. FKBP52 (-/-) females are sterile due to a complete failure of implantation, a process that requires estrogen (ER) and progesterone receptors (PR). Because the uterus expresses two forms of PR, PR-A and PR-B, we investigated all three receptors as potential targets of FKBP52 action. FKBP52 (-/-) uteri showed a normal growth response to estradiol, and unaltered expression of genes controlled by ER and PR-B. In contrast, FKBP52 (-/-) uteri were neither able to express two PR-A-regulated genes, nor undergo decidualization in response to progesterone, suggesting that FKBP52 specifically regulates PR-A at this organ. Analysis of uterine PR heterocomplexes showed preferential association of FKBP52 with PR-A compared with PR-B. Loss of FKBP52 neither disrupted the PR-A/heat shock protein 90 interaction, nor impaired uterine PR-A hormone-binding function, demonstrating the essential role of FKBP52 in PR-A action to be downstream of the hormone-binding event. Transcription studies in +/+ and -/- mouse embryonic fibroblast cells showed a near-complete loss of PR-A activity at mouse mammary tumor virus and synthetic progesterone response element promoters, although partial reductions of ER and PR-B were also observed. Partial disruptions of ovulation and mammary development were also found in FKBP52 (-/-) females. Taken as a whole, our results show FKBP52 to be an essential regulator of PR-A action in the uterus, while being a nonessential but contributory regulator of steroid receptors in the mammary and ovary. These data may now provide the basis for selective targeting of steroid-regulated physiology through tetratricopeptide repeat proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16873445      PMCID: PMC2661205          DOI: 10.1210/me.2006-0024

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  45 in total

1.  The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo.

Authors:  Daniel L Riggs; Patricia J Roberts; Samantha C Chirillo; Joyce Cheung-Flynn; Viravan Prapapanich; Thomas Ratajczak; Richard Gaber; Didier Picard; David F Smith
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

2.  Binding of hsp90-associated immunophilins to cytoplasmic dynein: direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain.

Authors:  Mario D Galigniana; Jennifer M Harrell; Patrick J M Murphy; Michael Chinkers; Christine Radanyi; Jack-Michel Renoir; Mingjie Zhang; William B Pratt
Journal:  Biochemistry       Date:  2002-11-19       Impact factor: 3.162

3.  A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins.

Authors:  Todd H Davies; Yang-Min Ning; Edwin R Sánchez
Journal:  J Biol Chem       Date:  2001-12-20       Impact factor: 5.157

4.  Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation.

Authors:  Susanne Tranguch; Joyce Cheung-Flynn; Takiko Daikoku; Viravan Prapapanich; Marc B Cox; Huirong Xie; Haibin Wang; Sanjoy K Das; David F Smith; Sudhansu K Dey
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-21       Impact factor: 11.205

5.  Physiological role for the cochaperone FKBP52 in androgen receptor signaling.

Authors:  Joyce Cheung-Flynn; Viravan Prapapanich; Marc B Cox; Daniel L Riggs; Carlos Suarez-Quian; David F Smith
Journal:  Mol Endocrinol       Date:  2005-04-14

6.  Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors.

Authors:  Weihong Zhao; Li Zhong; Jianqing Wu; Linyuan Chen; Keyun Qing; Kirsten A Weigel-Kelley; Steven H Larsen; Weinian Shou; Kenneth H Warrington; Arun Srivastava
Journal:  Virology       Date:  2006-07-10       Impact factor: 3.616

7.  Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform.

Authors:  B Mulac-Jericevic; R A Mullinax; F J DeMayo; J P Lydon; O M Conneely
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

8.  The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.

Authors:  P H Giangrande; E A Kimbrel; D P Edwards; D P McDonnell
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

9.  Different regions of the immunophilin FKBP52 determine its association with the glucocorticoid receptor, hsp90, and cytoplasmic dynein.

Authors:  A M Silverstein; M D Galigniana; K C Kanelakis; C Radanyi; J M Renoir; W B Pratt
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

10.  Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.

Authors:  Todd H Davies; Yang-Min Ning; Edwin R Sánchez
Journal:  Biochemistry       Date:  2005-02-15       Impact factor: 3.162

View more
  50 in total

Review 1.  Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52).

Authors:  Jeffrey C Sivils; Cheryl L Storer; Mario D Galigniana; Marc B Cox
Journal:  Curr Opin Pharmacol       Date:  2011-04-19       Impact factor: 5.547

Review 2.  Versatile TPR domains accommodate different modes of target protein recognition and function.

Authors:  Rudi Kenneth Allan; Thomas Ratajczak
Journal:  Cell Stress Chaperones       Date:  2010-12-09       Impact factor: 3.667

3.  Estrogen replacement regimen and brain infusion of lipopolysaccharide differentially alter steroid receptor expression in the uterus and hypothalamus.

Authors:  L K Marriott; K R McGann-Gramling; B Hauss-Wegrzyniak; L C Sheldahl; R A Shapiro; D M Dorsa; G L Wenk
Journal:  Endocrine       Date:  2008-02-05       Impact factor: 3.633

Review 4.  Minireview: the intersection of steroid receptors with molecular chaperones: observations and questions.

Authors:  David F Smith; David O Toft
Journal:  Mol Endocrinol       Date:  2008-05-01

Review 5.  The regulation of embryo implantation and endometrial decidualization by progesterone receptor signaling.

Authors:  Michael J Large; Francesco J DeMayo
Journal:  Mol Cell Endocrinol       Date:  2011-07-28       Impact factor: 4.102

Review 6.  FKBP51 and FKBP52 in signaling and disease.

Authors:  Cheryl L Storer; Chad A Dickey; Mario D Galigniana; Theo Rein; Marc B Cox
Journal:  Trends Endocrinol Metab       Date:  2011-08-31       Impact factor: 12.015

7.  Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity.

Authors:  Irene M Wolf; Sumudra Periyasamy; Terry Hinds; Weidong Yong; Weinian Shou; Edwin R Sanchez
Journal:  J Steroid Biochem Mol Biol       Date:  2008-11-27       Impact factor: 4.292

8.  FKBP52 deficiency-conferred uterine progesterone resistance is genetic background and pregnancy stage specific.

Authors:  Susanne Tranguch; Haibin Wang; Takiko Daikoku; Huirong Xie; David F Smith; Sudhansu K Dey
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 9.  Mechanisms of implantation: strategies for successful pregnancy.

Authors:  Jeeyeon Cha; Xiaofei Sun; Sudhansu K Dey
Journal:  Nat Med       Date:  2012-12       Impact factor: 53.440

10.  Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors.

Authors:  Jan-Philip Schülke; Gabriela Monika Wochnik; Isabelle Lang-Rollin; Nils Christian Gassen; Regina Theresia Knapp; Barbara Berning; Alexander Yassouridis; Theo Rein
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.